Trial intelligence / Profile preview

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts

NCT00000216Phase 3Completed

Sponsor
Yale University
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of buprenorphine in opioid use disorder (OUD), cocaine-related disorders, sponsored by Yale University. Status: completed.

02

Drugs

buprenorphine
03

Conditions

opioid use disorder (OUD)cocaine-related disorders

Beyond the preview

Go deeper on NCT00000216.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000216.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call